• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Buyouts

German health minister's 'locust sponsors' comments spook live healthcare deals

  • Rachel Lewis , Min Ho , Christel Thunell , Patrick Costello and Johannes Koch
  • 25 January 2023
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Sponsors are rethinking new platform deals in German healthcare following stark remarks by health minister Karl Lauterbach pushing to curtail private investment in the outpatient sector, market sources watching the situation told sister publication Mergermarket.

This has also resulted in investors already present in the sector to rush to get bolt-on deals across the line before any new rules come into play, the sources said.

In an interview with tabloid Bild published on 24 December, the minister said he will look to introduce legislation this quarter to stop "these locusts" from acquiring clinics, known locally as MVZs, adding that a profit margin of 10% or more is unjustifiable.

The remarks have made sponsors wary, lawyers, advisors and funds told this news service. One lawyer added that at the most extreme, the possibility will completely remove private equity from the market, despite nobody knowing at this stage what is constitutionally possible.

"Any new platform deals and new investors all seem to be on hold," the same lawyer said, adding that he recently advised one international fund to reconsider a bid on a dental asset, citing too much uncertainty when investing a limited partner's money.

Live deals that could be partly affected by the minister's remarks include Nordic Capital's plans to exit of European Dental Group, Equity Capital Management's sale process for skin care specialist Dermatologikum, and Gilde Healthcare's expected sale of imaging platform RAD-x, while other deals like NORD Holding's ophthalmology group Zentrum Gesundheit are chugging along without a buyer.

"Of course, I see that private equity is already pulling back from investments in the sector," a second lawyer said, although another source added that investors are also spooked by wider macro woes in valuation declines and debt financing.

Outpatient sectors like radiology, ophthalmology and dentistry are most likely to be affected by any new legislation, the sources said, where sponsors like EQT Infrastructure and Montagu have in recent years ploughed capital into consolidating platforms like Meine Radiologie and Artemis that are now ripe for exits.

Any new legal measures could also affect new entrants to the sector like family-office GBL, which acquired Sanoptis last April, and CVC-owned Finnish strategic Mehilainen, which sees the country as a core growth market.

Bolt rush
Some of these large vendors are impatiently seeking to strike deals now instead of waiting, in anticipation of any radical changes to future restrictions, one fund operating in the market said, and there are also a lot of small, founder-owned clinics with succession issues now looking for a quick exit, one of the lawyers said.

This is creating opportunities for bolt-ons for the larger platforms, with one lawyer saying that these deals now take up 90% of his pipeline.

If new limits do come into play, sponsors that already own assets are likely to be protected by grandfathering exemptions so they are not forced to sell out, one of the lawyers said.

That means sponsors are also rushing to acquire so-called "plan hospitals", which are a prerequisite under German TSVG law to owning outpatient groups, the lawyer continued.

"People are buying like crazy to get deals over the line before anything comes into effect," one of the lawyers said, "particularly buying the plan hospitals that give the necessary licence to own hospitals. Once that bottleneck is out of the way then people should be more relaxed."

Last year, Mehilainen acquired the necessary hospital to operate in the German market, alongside sponsor Warburg Pincus, which does not otherwise own an outpatient group.

Intense lobbying
Lauterbach's remarks have yet to be put into legislation, and one lawyer told this news service that formal documents have already been pushed back to the second or third quarter of the year, and will likely be watered down or stopped completely by coalition partners in the Department of Justice.

One key roadblock to such legislation is a strong basis for the international investment community in Germany to succeed in compensation-loss claims against the government, much like Swedish energy group Vattenfall when the Bundestag prematurely phased out nuclear power production in Germany in 2011, the same source said.

There is precedent for German healthcare reforms impacting M&A. Last year, the state ruled that increased pay for caregivers could not be passed on to patients, which partially fed through to low appetite for Nordic Capital's care home group Alloheim, which struggled to present normalised earnings.

Doctors themselves are fighting on either side; one source suggested that Lauterbach is in an informal coalition with powerful doctor lobbies that want to protect their assets.

On the other side of the equation, younger doctors like that private capital prevent them from spending millions of their own money on capex like new machines, and appreciate structures that can help female doctors, especially, take time off to have children, one of the lawyers said.

"Doctors wouldn't even get out of bed for 10%," this lawyer said. "Most have 30-50% margins, which is deserved, and will want to keep it that way."

For now, some private equity firms and advisors are now lining up with their lawyers to assess the potential full impact of the proposed law, a sector banker said. "It could definitely impact dealmaking, but we need to understand it a bit more. It's definitely led to a higher level of caution in the community."

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • GPs
  • Regulation
  • DACH
  • Healthcare
  • Expansion
  • Germany
  • healthcare
  • Nordic Capital
  • Gilde Buy Out Partners
  • ECM Equity Capital Management
  • Nord Holding
  • EQT
  • CVC Capital Partners
  • Warburg Pincus

More on Buyouts

Permira to take Ergomed private for GBP 703m
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
Main Capital's Assessio to be sold to Pollen Street
Main Capital's Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
TPG takes majority control of A-Gas, doubles down on impact investing
TPG takes majority control of A-Gas, doubles down on impact investing

KKR partially exits its 2017 investment in the specialty gas and chemical distributor, retaining a minority stake

  • Buyouts
  • 18 August 2023
Quadrivio to capitalise on baby boomers as it nears wrap for its new EUR 300m fund
Quadrivio to capitalise on baby boomers as it nears wrap for its new EUR 300m fund

The Silver Economy Fund makes its second investment as it highlights trend of GPs doubling down on narrow strategies

  • Buyouts
  • 16 August 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013